Gregory Rutecki, MD

vinay Shah,M.D.

970 - Clifton Ave.

Clifton

07011

Articles

SGLT2 Inhibitors: Pros, Cons, Comparisons, and Considerations

July 23, 2014

There are 2 FDA-approved sodium-glucose contransporter-2 inhibitors available in the United States. Here, a concise review of advantages/disadvantages and considerations in patient selection.